Clinical Laserthermia Systems AB (publ) Financial Flexibility Index
Clinical Laserthermia Systems AB (publ) financial flexibility index. Clinical Laserthermia Systems AB (publ) (CLS-B) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of Skr-297.00K (operating CF Skr-4.73 Million minus capex Skr4.43 Million) represents 0% of total liabilities (Skr22.07 Million). See CLS-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Clinical Laserthermia Systems AB (publ) (2008–2025)
Financial flexibility index of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. Historical Financial Flexibility Index trend for Clinical Laserthermia Systems AB (publ) across 18 annual periods. Explore CLS-B cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Clinical Laserthermia Systems AB (publ) Financial Flexibility Index by Year (2008–2025)
Clinical Laserthermia Systems AB (publ) financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Clinical Laserthermia Systems AB (publ). For the full cash flow conversion analysis, see Clinical Laserthermia Systems AB (publ) cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.04x | Skr-30.41 Million | Skr-33.20 Million | Skr10.00 Million | ▲ +27.5% |
| 2024 | -4.19x | Skr-53.99 Million | Skr-56.45 Million | Skr12.88 Million | ▲ +2.3% |
| 2023 | -4.29x | Skr-60.96 Million | Skr-66.45 Million | Skr14.20 Million | ▼ -155.0% |
| 2022 | -1.68x | Skr-70.13 Million | Skr-70.69 Million | Skr41.64 Million | ▼ -16.9% |
| 2021 | -1.44x | Skr-65.62 Million | Skr-66.17 Million | Skr45.55 Million | ▲ +20.3% |
| 2020 | -1.81x | Skr-55.06 Million | Skr-55.41 Million | Skr30.47 Million | ▼ -47.6% |
| 2019 | -1.22x | Skr-38.77 Million | Skr-39.12 Million | Skr31.67 Million | ▲ +72.3% |
| 2018 | -4.43x | Skr-36.35 Million | Skr-38.72 Million | Skr8.21 Million | ▼ -168.1% |
| 2017 | -1.65x | Skr-19.71 Million | Skr-24.39 Million | Skr11.94 Million | ▲ +6.5% |
| 2016 | -1.77x | Skr-18.09 Million | Skr-19.63 Million | Skr10.24 Million | ▲ +70.5% |
| 2015 | -5.98x | Skr-16.78 Million | Skr-18.68 Million | Skr2.81 Million | ▼ -141.3% |
| 2014 | -2.48x | Skr-13.33 Million | Skr-15.74 Million | Skr5.38 Million | ▲ +51.4% |
| 2013 | -5.10x | Skr-15.86 Million | Skr-18.30 Million | Skr3.11 Million | ▼ -51.6% |
| 2012 | -3.36x | Skr-9.99 Million | Skr-12.05 Million | Skr2.97 Million | ▼ -75.5% |
| 2011 | -1.92x | Skr-4.17 Million | Skr-5.96 Million | Skr2.17 Million | ▲ +10.6% |
| 2010 | -2.14x | Skr-3.01 Million | Skr-4.92 Million | Skr1.41 Million | ▼ -424.7% |
| 2009 | 0.66x | Skr1.04 Million | Skr-2.28 Million | Skr1.57 Million | ▼ -37.2% |
| 2008 | 1.05x | Skr1.94 Million | Skr-69.30K | Skr1.85 Million | — |